Richard H. Ebright

18.9k total citations · 2 hit papers
181 papers, 14.5k citations indexed

About

Richard H. Ebright is a scholar working on Molecular Biology, Genetics and Ecology. According to data from OpenAlex, Richard H. Ebright has authored 181 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Molecular Biology, 91 papers in Genetics and 28 papers in Ecology. Recurrent topics in Richard H. Ebright's work include RNA and protein synthesis mechanisms (114 papers), Bacterial Genetics and Biotechnology (87 papers) and DNA and Nucleic Acid Chemistry (49 papers). Richard H. Ebright is often cited by papers focused on RNA and protein synthesis mechanisms (114 papers), Bacterial Genetics and Biotechnology (87 papers) and DNA and Nucleic Acid Chemistry (49 papers). Richard H. Ebright collaborates with scholars based in United States, United Kingdom and Czechia. Richard H. Ebright's co-authors include Yon W. Ebright, Stephen Busby, Achillefs N. Kapanidis, Hong Tang, Danny Reinberg, Angelo Gunasekera, Nataliya Popovych, Andrey Revyakin, Charalampos G. Kalodimos and Helen M. Berman and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Richard H. Ebright

180 papers receiving 14.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transcription activation by catabolite activator protein (CAP)

1999 654 citations Richard H. Ebright et al. profile →
Dynamically driven protein allostery

2006 518 citations Nataliya Popovych, Richard H. Ebright et al. profile →

Peers

Countries citing papers authored by Richard H. Ebright

Since Specialization

Citations

This map shows the geographic impact of Richard H. Ebright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Ebright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Ebright more than expected).

Fields of papers citing papers by Richard H. Ebright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Ebright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Ebright. The network helps show where Richard H. Ebright may publish in the future.

Co-authorship network of co-authors of Richard H. Ebright

This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Ebright. A scholar is included among the top collaborators of Richard H. Ebright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Ebright. Richard H. Ebright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bacillus subtilis σ ^A and Escherichia coli σ ⁷⁰ lacking σ region 1.1 are not released during transcription initiation and elongation 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), (unknown), Yon W. Ebright, Richard H. Ebright, (unknown)	1
2	Nanopore tweezers show fractional-nucleotide translocation in sequence-dependent pausing by RNA polymerase 2024 ·Proceedings of the National Academy of Sciences ·Ian C. Nova, Jonathan M. Craig, Abhishek Mazumder, Andrew H. Laszlo, Ian M. Derrington, (unknown), Henry Brinkerhoff, (unknown), Hanif Vahedian-Movahed, Lingting Li, Yu Zhang, (unknown), (unknown), (unknown), Richard H. Ebright, Jens H. Gundlach	4
3	Identification and Structural Modeling of the RNA Polymerase Omega Subunits in Chlamydiae and Other Obligate Intracellular Bacteria 2023 ·mBio ·Andrew Y. S. Cheng, (unknown), (unknown), Chengyuan Wang, (unknown), Joseph D. Fondell, Richard H. Ebright, Huizhou Fan	2
4	Structural and mechanistic basis of σ-dependent transcriptional pausing 2022 ·Proceedings of the National Academy of Sciences ·(unknown), Vadim Molodtsov, Mahdi Kooshkbaghi, Ammar Tareen, (unknown), (unknown), Min Su, Yin Zhou, Jared T. Winkelman, Justin B. Kinney, Richard H. Ebright, Bryce E. Nickels	8
5	Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens 2022 ·Journal of Medicinal Chemistry ·Zhenkun Ma, (unknown), Ying Yuan, (unknown), Yu Liu, Huan Wang, Jing Chen, (unknown), Charles Z. Ding, Vadim Molodtsov, Wei Lin, Gregory T. Robertson, Jason Weiss, Mark Pulse, Phung M. Nguyen, Leonard R Duncan, Timothy B Doyle, Richard H. Ebright, A. Simon Lynch	18
6	Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance 2022 ·Angewandte Chemie ·Tian Lan, Uday S. Ganapathy, Sachin Sharma, (unknown), Matthew Zimmerman, Vadim Molodtsov, (unknown), Martin Gengenbacher, Richard H. Ebright, Véronique Dartois, Joel S. Freundlich, Thomas Dick, Courtney C. Aldrich	2
7	Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance 2022 ·Angewandte Chemie International Edition ·Tian Lan, Uday S. Ganapathy, Sachin Sharma, (unknown), Matthew Zimmerman, Vadim Molodtsov, (unknown), Martin Gengenbacher, Richard H. Ebright, Véronique Dartois, Joel S. Freundlich, Thomas Dick, Courtney C. Aldrich	15
8	RNA polymerase clamp conformational dynamics: long-lived states and modulation by crowding, cations, and nonspecific DNA binding 2021 ·Nucleic Acids Research ·Abhishek Mazumder, (unknown), (unknown), Richard H. Ebright, Achillefs N. Kapanidis	11
9	Promoter-sequence determinants and structural basis of primer-dependent transcription initiation in Escherichia coli 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Lingting Li, Yuanchao Zhang, Irina O. Vvedenskaya, Jared T. Winkelman, (unknown), Deanne Taylor, Premal Shah, Richard H. Ebright, Justin B. Kinney, Yu Zhang, Bryce E. Nickels	7
10	Comment of a critical review about the origins of SARS-CoV-2 2021 ·Zenodo (CERN European Organization for Nuclear Research) ·François Graner, Virginie Courtier‐Orgogozo, Étienne Decroly, Colin D. Butler, Richard H. Ebright, (unknown), Bernd Kaina, Monali C. Rahalkar, José Halloy, Rahul A. Bahulikar, Günter Theißen, Milton Leitenberg, Sergé Morand, Hideki Kakeya, Jean‐Michel Claverie, Jacques van Helden	1
11	Transcription initiation at a consensus bacterial promoter proceeds via a ‘bind-unwind-load-and-lock’ mechanism 2021 ·eLife ·Abhishek Mazumder, Richard H. Ebright, Achillefs N. Kapanidis	14
12	Closing and opening of the RNA polymerase trigger loop 2020 ·Proceedings of the National Academy of Sciences ·Abhishek Mazumder, Miaoxin Lin, Achillefs N. Kapanidis, Richard H. Ebright	26
13	Structural basis of transcription-translation coupling 2020 ·Science ·Chengyuan Wang, Vadim Molodtsov, Emre Firlar, Jason T. Kaelber, Gregor Blaha, Min Su, Richard H. Ebright	97
14	Structural basis of ECF-σ-factor-dependent transcription initiation 2019 ·Nature Communications ·Wei Lin, Sukhendu Mandal, David Degen, (unknown), Yu Feng, Kalyan Das, Richard H. Ebright	32
15	Functionalised bicyclic tetramates derived from cysteine as antibacterial agents 2019 ·Organic & Biomolecular Chemistry ·Tharindi Panduwawala, Sarosh Iqbal, Amber L. Thompson, Miroslav Genov, Alexander Pretsch, (unknown), Shuang Liu, Richard H. Ebright, Alison J. Howells, Anthony Maxwell, Mark G. Moloney	12
16	Structural Basis of Transcription Initiation 2012 ·Science ·Yu Zhang, Yu Feng, Sujoy Chatterjee, Steve Tuske, Mary Ho, Eddy Arnold, Richard H. Ebright	322
17	Structural basis for cAMP-mediated allosteric control of the catabolite activator protein 2009 ·Proceedings of the National Academy of Sciences ·Nataliya Popovych, Shiou‐Ru Tzeng, Marco Tonelli, Richard H. Ebright, Charalampos G. Kalodimos	178
18	Direct Detection of Abortive RNA Transcripts in Vivo 2009 ·Science ·Seth Goldman, Richard H. Ebright, Bryce E. Nickels	90
19	The interaction between σ ⁷⁰ and the β-flap of Escherichia coli RNA polymerase inhibits extension of nascent RNA during early elongation 2005 ·Proceedings of the National Academy of Sciences ·Bryce E. Nickels, (unknown), Vladimir Mekler, Leonid Minakhin, Konstantin Severinov, Richard H. Ebright, Ann Hochschild	72
20	Structural Basis of Transcription Activation: The CAP-αCTD-DNA Complex 2002 ·Science ·B. Benoff, Huanwang Yang, Catherine L. Lawson, Gary N. Parkinson, Jinsong Liu, Erich E. Blatter, Yon W. Ebright, Helen M. Berman, Richard H. Ebright	205

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact